UBS AG - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 132 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS AG ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$3,075,000
+10.9%
31,724
+5.0%
0.00%0.0%
Q2 2014$2,774,000
+222.9%
30,200
+146.2%
0.00%
+100.0%
Q1 2014$859,000
-39.3%
12,268
-50.2%
0.00%0.0%
Q4 2013$1,415,000
-30.8%
24,624
-42.1%
0.00%0.0%
Q3 2013$2,045,000
+61.2%
42,534
-2.8%
0.00%0.0%
Q2 2013$1,269,00043,7400.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders